Digital Pharma’s new gatekeeper: AI’s rising role The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.
News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
